Skip to main content

Cigna Group

For the period ended Mar 31, 2024. Filed May 2, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 2, 2024

CI$303.13+2.5%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Statements of Income

The Cigna GroupConsolidated Statements of Income
Unaudited
Three Months Ended March 31,
(In millions, except per share amounts)20242023
Revenues
Pharmacy revenues$42,036$32,144
Premiums11,60311,025
Fees and other revenues3,3263,071
Net investment income290277
TOTAL REVENUES57,25546,517
Benefits and expenses
Pharmacy and other service costs41,43131,459
Medical costs and other benefit expenses9,4409,046
Selling, general and administrative expenses3,7053,538
Amortization of acquired intangible assets423459
TOTAL BENEFITS AND EXPENSES54,99944,502
Income from operations2,2562,015
Interest expense and other(322)(358)
Loss on sale of businesses(19)—
Net realized investment losses(1,836)(56)
Income before income taxes791,601
TOTAL INCOME TAXES291295
Net (loss) income(212)1,306
Less: Net income attributable to noncontrolling interests6539
SHAREHOLDERS' NET (LOSS) INCOME$(277)$1,267
Shareholders' net (loss) income per share
Basic$(0.97)$4.28
Diluted$(0.97)$4.24
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.